|
1
|
Stieber JR and Dormans JP: Manifestations
of hereditary multiple exostoses. J Am Acad Orthop Surg.
13:110–120. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jones KB: Glycobiology and the growth
plate: Current concepts in multiple hereditary exostoses. J Pediatr
Orthop. 31:577–586. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wicklund CL, Pauli RM, Johnston D and
Hecht JT: Natural history study of hereditary multiple exostoses.
Am J Med Genet. 55:43–46. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schmale GA, Conrad EU III and Raskind WH:
The natural history of hereditary multiple exostoses. J Bone Joint
Surg Am. 76:986–992. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Porter DE, Lonie L, Fraser M, Dobson-Stone
C, Porter JR, Monaco AP and Simpson AH: Severity of disease and
risk of malignant change in hereditary multiple exostoses. A
genotype-phenotype study. J Bone Joint Surg Br. 86:1041–1046. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Porter DE and Simpson AH: The neoplastic
pathogenesis of solitary and multiple osteochondromas. J Pathol.
188:119–125. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahn J, Lüdecke HJ, Lindow S, Horton WA,
Lee B, Wagner MJ, Horsthemke B and Wells DE: Cloning of the
putative tumour suppressor gene for hereditary multiple exostoses
(EXT1). Nat Genet. 11:137–143. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hecht JT, Hogue D, Strong LC, Hansen MF,
Blanton SH and Wagner M: Hereditary multiple exostosis and
chondrosarcoma: Linkage to chromosome II and loss of heterozygosity
for EXT-linked markers on chromosomes II and 8. Am J Hum Genet.
56:1125–1131. 1995.PubMed/NCBI
|
|
9
|
Wuyts W and Van Hul W: Molecular basis of
multiple exostoses: Mutations in the EXT1 and EXT2 genes. Hum
Mutat. 15:220–227. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Szuhai K, Jennes I, de Jong D, Bovée JV,
Wiweger M, Wuyts W and Hogendoorn PC: Tiling resolution array-CGH
shows that somatic mosaic deletion of the EXT gene is causative in
EXT gene mutation negative multiple osteochondromas patients. Hum
Mutat. 32:E2036–E2049. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jennes I, Pedrini E, Zuntini M, Mordenti
M, Balkassmi S, Asteggiano CG, Casey B, Bakker B, Sangiorgi L and
Wuyts W: Multiple osteochondromas: Mutation update and description
of the multiple osteochondromas mutation database (MOdb). Hum
Mutat. 30:1620–1627. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stickens D, Clines G, Burbee D, Ramos P,
Thomas S, Hogue D, Hecht JT, Lovett M and Evans GA: The EXT2
multiple exostoses gene defines a family of putative tumour
suppressor genes. Nat Genet. 14:25–32. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
McCormick C, Duncan G, Goutsos KT and
Tufaro F: The putative tumor suppressors EXT1 and EXT2 form a
stable complex that accumulates in the Golgi apparatus and
catalyzes the synthesis of heparan sulfate. Proc Natl Acad Sci USA.
97:668–673. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Takei Y, Ozawa Y, Sato M, Watanabe A and
Tabata T: Three Drosophila EXT genes shape morphogen gradients
through synthesis of heparan sulfate proteoglycans. Development.
131:73–82. 2004. View Article : Google Scholar
|
|
15
|
Zak BM, Schuksz M, Koyama E, Mundy C,
Wells DE, Yamaguchi Y, Pacifici M and Esko JD: Compound
heterozygous loss of Ext1 and Ext2 is sufficient for formation of
multiple exostoses in mouse ribs and long bones. Bone. 48:979–987.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jones KB, Piombo V, Searby C, Kurriger G,
Yang B, Grabellus F, Roughley PJ, Morcuende JA, Buckwalter JA,
Capecchi MR, et al: A mouse model of osteochondromagenesis from
clonal inactivation of Ext1 in chondrocytes. Proc Natl Acad Sci
USA. 107:2054–2059. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Matsumoto K, Irie F, Mackem S and
Yamaguchi Y: A mouse model of chondrocyte-specific somatic mutation
reveals a role for Ext1 loss of heterozygosity in multiple
hereditary exostoses. Proc Natl Acad Sci USA. 107:10932–10937.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zuntini M, Pedrini E, Parra A, Sgariglia
F, Gentile FV, Pandolfi M, Alberghini M and Sangiorgi L: Genetic
models of osteochondroma onset and neoplastic progression: Evidence
for mechanisms alternative to EXT genes inactivation. Oncogene.
29:3827–3834. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reijnders CM, Waaijer CJ, Hamilton A,
Buddingh EP, Dijkstra SP, Ham J, Bakker E, Szuhai K, Karperien M,
Hogendoorn PC, et al: No haploinsufficiency but loss of
heterozygosity for EXT in multiple osteochondromas. Am J Pathol.
177:1946–1957. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barash Y, Calarco JA, Gao W, Pan Q, Wang
X, Shai O, Blencowe BJ and Frey BJ: Deciphering the splicing code.
Nature. 465:53–59. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang GS and Cooper TA: Splicing in
disease: Disruption of the splicing code and the decoding
machinery. Nat Rev Genet. 8:749–761. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian C, Yan R, Wen S, Li X, Li T, Cai Z,
Li X, Du H and Chen H: A splice mutation and mRNA decay of EXT2
provoke hereditary multiple exostoses. PLoS One. 9:e948482014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen XJ, Zhang H, Tan ZP, Hu W and Yang
YF: Novel mutation of EXT2 identified in a large family with
multiple osteochondromas. Mol Med Rep. 14:4687–4691. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bovée JV: Multiple osteochondromas.
Orphanet J Rare Dis. 3:32008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wuyts W, Radersma R, Storm K and Vits L:
An optimized DHPLC protocol for molecular testing of the EXT1 and
EXT2 genes in hereditary multiple osteochondromas. Clin Genet.
68:542–547. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Divina P, Kvitkovicova A, Buratti E and
Vorechovsky I: Ab initio prediction of mutation-induced cryptic
splice-site activation and exon skipping. Eur J Hum Genet.
17:759–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Desmet FO, Hamroun D, Lalande M,
Collod-Béroud G, Claustres M and Béroud C: Human Splicing Finder:
An online bioinformatics tool to predict splicing signals. Nucleic
Acids Res. 37:e672009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Lizée G, Aerts JL, Gonzales MI, Chinnasamy
N, Morgan RA and Topalian SL: Real-time quantitative reverse
transcriptase-polymerase chain reaction as a method for determining
lentiviral vector titers and measuring transgene expression. Hum
Gene Ther. 14:497–507. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kobayashi S, Morimoto K, Shimizu T,
Takahashi M, Kurosawa H and Shirasawa T: Association of EXT1 and
EXT2, hereditary multiple exostoses gene products, in Golgi
apparatus. Biochem Biophys Res Commun. 268:860–867. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Xie BB, Li D, Shi WL, Qin QL, Wang XW,
Rong JC, Sun CY, Huang F, Zhang XY, Dong XW, et al: Deep RNA
sequencing reveals a high frequency of alternative splicing events
in the fungus Trichoderma longibrachiatum. BMC Genomics. 16:542015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Clement ND and Porter DE: Hereditary
multiple exostoses: Anatomical distribution and burden of exostoses
is dependent upon genotype and gender. Scott Med J. 59:35–44. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pedrini E, Jennes I, Tremosini M, Milanesi
A, Mordenti M, Parra A, Sgariglia F, Zuntini M, Campanacci L,
Fabbri N, et al: Genotype-phenotype correlation study in 529
patients with multiple hereditary exostoses: Identification of
'protective' and 'risk' factors. J Bone Joint Surg Am.
93:2294–2302. 2011. View Article : Google Scholar
|
|
34
|
Busse M, Feta A, Presto J, Wilén M,
Grønning M, Kjellén L and Kusche-Gullberg M: Contribution of EXT1,
EXT2, and EXTL3 to heparan sulfate chain elongation. J Biol Chem.
282:32802–32810. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bobadilla S, Sunseri N and Landau NR:
Efficient transduction of myeloid cells by an HIV-1-derived
lentiviral vector that packages the Vpx accessory protein. Gene
Ther. 20:514–520. 2013. View Article : Google Scholar
|
|
36
|
Nukuzuma S, Nakamichi K, Kameoka M,
Sugiura S, Nukuzuma C, Miyoshi I and Takegami T: Efficient
propagation of progressive multifocal leukoencephalopathy-type JC
virus in COS-7-derived cell lines stably expressing Tat protein of
human immunodeficiency virus type 1. Microbiol Immunol. 54:758–762.
2010. View Article : Google Scholar
|
